课题基金 / 基金详情

How are the cells on the surface of embryoid body derived from ES cells induced to differentiate into primitive endoderm?

How are the cells on the surface of embryoid body derived from ES cells induced to differentiate into primitive endoderm?
ES细胞衍生的拟胚体表面细胞是如何被诱导分化为原始内胚层的?
批准号:
16370099
负责人:
NIWA Hitoshi
金额:
$9.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

NIWA Hitoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this research project, we first hypothesized that the extracellular signals derived from the adhesion to the extracellular matrix via integrin and the cell-to-cell adhesion via cadherin would involve in the maintenance of pluripotency in mouse ES cells in cooperation to the soluble factors. To test this model, we plotted the inhibition of the integrain signal by overexpressing the dominant-negative mutant of integrin-linked kinase (ILK) and found that it partially induce differentiation in the presence of differentiation inhibitor LIF. We also tried to test the function of the E-cadherin-mediated signal on induction of differentiation toward primitive endoderm on the surface of aggregates in suspension culture condition. When we put the soluble form of the extracellular domain of E-cadherin in this culture, differentiation of primitive endoderm is interfered, suggesting that the reduced amount of E-cadherin signal might trigger differentiation in the cells locating the surface of the aggregates.These extracellular signals determine the cell fate by modulating the expression of the transcription factors. We found that the ectopic expression of zinc-finger transcription factor Gata6 induces differentiation of ES cells into primitive endoderm cells that mimic the phenotype of embryo-derived XEN cells. As the model system to control cell fate by transcription factors, we revealed that the reciprocal inhibition system between Cdx2, which determines differentiation to trophectoderm, and the pluripotency-associated transcription factor Oct3/4 involves in segregation between pluripotent cell and trophectoderm lineages. In addition, we also made it clear how the other pluripotency-associated transcription factor Sox2 works in ES cells. These findings will contribute to analyze the mechanism to direct primitive endoderm differentiation.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1093/nar/gni043
发表时间: 2005-03-01
期刊: Nucleic acids research
影响因子: 14.9
作者: [Masui S, Shimosato D, Toyooka Y, Yagi R, Takahashi K, Niwa H]
通讯作者: Niwa H
DOI: 10.1128/mcb.24.10.4207-4220.2004
发表时间: 2004-05-01
期刊: MOLECULAR AND CELLULAR BIOLOGY
影响因子: 5.3
作者: [Miyagi, S, Saito, T, Okuda, A]
通讯作者: Okuda, A
Oct-3/4 and Sox2 regulate Oct3/4 gene in ES cells.
Oct-3/4 和 Sox2 调节 ES 细胞中的 Oct3/4 基因。
DOI: --
发表时间: 2005
期刊: J. Biol. Chem. 280
影响因子: --
作者: [Okumura-Nakanishi, S., et al.]
通讯作者: et al.
The soox-2 regulatory regions display their activities in two distinct types of multipotent stem cells.
soox-2 调节区在两种不同类型的多能干细胞中显示出其活性。
DOI: --
发表时间: 2004
期刊: Mol. Cell. Biol 24
影响因子: --
作者: [Miyagi S., et al.]
通讯作者: et al.
Behavioral responses and Fos activation following orofacial formalin injection in a rodent model of Parkinson's disease
  • 批准号:
    23592988
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.33万
  • 财政年份:
    2011
  • 负责人:
    NIWA Hitoshi
  • 依托单位:
Pain sensations of oral region in rat models of Parkinson's disease
  • 批准号:
    20592371
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2008
  • 负责人:
    NIWA Hitoshi
  • 依托单位:
The effects of acupuncture on endocrine system, autonomic nervous system and cerebral function
  • 批准号:
    17592076
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.18万
  • 财政年份:
    2005
  • 负责人:
    NIWA Hitoshi
  • 依托单位:
ESTABLISHMENT OF FEEDER- AND SERUM-FREE CULTURE SYSTEM OF ES CELLS AND ITS APPLICATION TO PROPAGATE ES CELLS FROM INBRED MICE EMBRYOS
国内基金
海外基金
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位:
BRD4通过结合TEAD1调控β细胞增殖分化的机制研究
  • 批准号:
    82370801
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李峰
  • 依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
  • 批准号:
    82370906
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    代杰文
  • 依托单位:
新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
  • 批准号:
    82371711
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    吕志宝
  • 依托单位: